Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 2 records, 1 pages
Search For: Antibody-oligonucleotide Conjugates (AOCs)
Global Antibody-oligonucleotide Conjugates (AOCs) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
11 Oct 2024
Chemical & Material
Antibody-oligonucleotide Conjugates (AOCs)
Antibody-oligonucleotide Conjugations (AOCs) combines the properties of antibodies and oligonucleotides (such as antisense oligonucleotides, siRNA or aptamers). Antibodies are coupled to oligonucleotides by chemical or enzymatic methods to form such complexes, which enable them to target specific cells or tissues while releasing oligonucleotides with therapeutic or regulatory functions. They have broad application potential in cancer therapy, gene therapy and molecular diagnosis.
USD3480.00
Add To Cart
Global Antibody-oligonucleotide Conjugates (AOCs) Supply, Demand and Key Producers, 2024-2030
11 Oct 2024
Chemical & Material
Antibody-oligonucleotide Conjugates (AOCs)
Antibody-oligonucleotide Conjugations (AOCs) combines the properties of antibodies and oligonucleotides (such as antisense oligonucleotides, siRNA or aptamers). Antibodies are coupled to oligonucleotides by chemical or enzymatic methods to form such complexes, which enable them to target specific cells or tissues while releasing oligonucleotides with therapeutic or regulatory functions. They have broad application potential in cancer therapy, gene therapy and molecular diagnosis.
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
Search For: Antibody-oligonucleotide Conjugates (AOCs)
Total: 2 records, 1 pages
Antibody-oligonucleotide Conjugations (AOCs) combines the properties of antibodies and oligonucleotides (such as antisense oligonucleotides, siRNA or aptamers). Antibodies are coupled to oligonucleotides by chemical or enzymatic methods to form such complexes, which enable them to target specific cells or tissues while releasing oligonucleotides with therapeutic or regulatory functions. They have broad application potential in cancer therapy, gene therapy and molecular diagnosis.
USD3480.00
Add To Cart
Antibody-oligonucleotide Conjugations (AOCs) combines the properties of antibodies and oligonucleotides (such as antisense oligonucleotides, siRNA or aptamers). Antibodies are coupled to oligonucleotides by chemical or enzymatic methods to form such complexes, which enable them to target specific cells or tissues while releasing oligonucleotides with therapeutic or regulatory functions. They have broad application potential in cancer therapy, gene therapy and molecular diagnosis.
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>